Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Gastrointestinal 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

Specimen Handling 36 Magnetic Resonance Spectroscopy 31 Cyclophosphamide 28 Doxorubicin 23 Biopsy 22 pembrolizumab 21 Temozolomide 21 X-Rays 17 Radiotherapy 17 Radiation 16 Nivolumab 13 fludarabine 12 atezolizumab 12 Vincristine 12 Phantoms, Imaging 12 Irinotecan 12 Ifosfamide 12 Gemcitabine 12 cabozantinib 10 Bevacizumab 9 liposomal doxorubicin 8 Surgical Procedures, Operative 8 Paclitaxel 8 Ipilimumab 8 Etoposide 8 Immunoglobulin G 7 Carboplatin 7 palbociclib 6 olaparib 6 fludarabine phosphate 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Base Sequence × Sarcoma × 90 days × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡